Thread: Novo says still expects FDA liraglutide approval - Reuters

Novo says still expects FDA liraglutide approval - Reuters





<img alt="" height="1" width="1"&gt;<img src=http://nt3.ggpht.com/news?imgefp=K4cVgNR1WC0J&imgurl=media.washingtonti mes.com/media/img/photos/2009/03/30/web_job_001_r329x151.JPG%3Fe315d4515574cec417b1845 392ba687dd98c17ce width=80 height=37 alt="" border=1>

Washington TimesNovo says still expects FDA liraglutide approval

Reuters

COPENHAGEN, April 3 (Reuters) - Novo Nordisk (NOVOb.CO) said it still expects the US Food and Drug Administration to approve its proposed diabetes medicine liraglutide, despite a split ruling on its safety by an advisory panel.

Novo Nordisk Still Committed To Liraglutide Launch Wall Street Journal

Novo Nordisk shares slump on FDA committee's split MarketWatch

Bloomberg - Reuters UK - The Associated Press - MedPage Todayall 162 news articles